CVS Health Statistics
Total Valuation
CVS Health has a market cap or net worth of $87.32 billion. The enterprise value is $155.25 billion.
| Market Cap | 87.32B |
| Enterprise Value | 155.25B |
Important Dates
The next confirmed earnings date is Wednesday, May 1, 2024, before market open.
| Earnings Date | May 1, 2024 |
| Ex-Dividend Date | Apr 19, 2024 |
Share Statistics
CVS Health has 1.26 billion shares outstanding. The number of shares has decreased by -2.49% in one year.
| Shares Outstanding | 1.26B |
| Shares Change (YoY) | -2.49% |
| Shares Change (QoQ) | +0.23% |
| Owned by Insiders (%) | 0.12% |
| Owned by Institutions (%) | 82.80% |
| Float | 1.25B |
Valuation Ratios
The trailing PE ratio is 10.72 and the forward PE ratio is 8.28. CVS Health's PEG ratio is 1.00.
| PE Ratio | 10.72 |
| Forward PE | 8.28 |
| PS Ratio | 0.24 |
| Forward PS | 0.23 |
| PB Ratio | 1.14 |
| P/FCF Ratio | 8.40 |
| PEG Ratio | 1.00 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.24, with an EV/FCF ratio of 14.94.
| EV / Earnings | 18.61 |
| EV / Sales | 0.43 |
| EV / EBITDA | 11.24 |
| EV / EBIT | 11.24 |
| EV / FCF | 14.94 |
Financial Position
The company has a current ratio of 0.86, with a Debt / Equity ratio of 1.04.
| Current Ratio | 0.86 |
| Quick Ratio | 0.59 |
| Debt / Equity | 1.04 |
| Debt / EBITDA | 5.75 |
| Debt / FCF | 7.64 |
| Interest Coverage | 5.19 |
Financial Efficiency
Return on equity (ROE) is 11.30% and return on invested capital (ROIC) is 6.60%.
| Return on Equity (ROE) | 11.30% |
| Return on Assets (ROA) | 3.40% |
| Return on Capital (ROIC) | 6.60% |
| Revenue Per Employee | $1.19M |
| Profits Per Employee | $27,813 |
| Employee Count | 300,000 |
| Asset Turnover | 1.45 |
| Inventory Turnover | 16.35 |
Taxes
In the past 12 months, CVS Health has paid $2.81 billion in taxes.
| Income Tax | 2.81B |
| Effective Tax Rate | 25.16% |
Stock Price Statistics
The stock price has decreased by -8.87% in the last 52 weeks. The beta is 0.51, so CVS Health's price volatility has been lower than the market average.
| Beta (1Y) | 0.51 |
| 52-Week Price Change | -8.87% |
| 50-Day Moving Average | 75.31 |
| 200-Day Moving Average | 72.74 |
| Relative Strength Index (RSI) | 31.45 |
| Average Volume (30 Days) | 10,113,991 |
Short Selling Information
The latest short interest is 22.72 million, so 1.81% of the outstanding shares have been sold short.
| Short Interest | 22.72M |
| Short Previous Month | 24.17M |
| Short % of Shares Out | 1.81% |
| Short % of Float | 1.81% |
| Short Ratio (days to cover) | 2.51 |
Income Statement
In the last 12 months, CVS Health had revenue of $357.78 billion and earned $8.34 billion in profits. Earnings per share was $6.47.
| Revenue | 357.78B |
| Gross Profit | 54.43B |
| Operating Income | 13.74B |
| Pretax Income | 11.15B |
| Net Income | 8.34B |
| EBITDA | 13.81B |
| EBIT | 13.81B |
| Earnings Per Share (EPS) | $6.47 |
Balance Sheet
The company has $11.46 billion in cash and $79.39 billion in debt, giving a net cash position of -$67.93 billion or -$53.98 per share.
| Cash & Cash Equivalents | 11.46B |
| Total Debt | 79.39B |
| Net Cash | -67.93B |
| Net Cash Per Share | -$53.98 |
| Equity / Book Value | 76.46B |
| Book Value Per Share | 60.76 |
| Working Capital | -11.33B |
Cash Flow
In the last 12 months, operating cash flow was $13.43 billion and capital expenditures -$3.03 billion, giving a free cash flow of $10.40 billion.
| Operating Cash Flow | 13.43B |
| Capital Expenditures | -3.03B |
| Free Cash Flow | 10.40B |
| FCF Per Share | $8.09 |
Margins
Gross margin is 15.21%, with operating and profit margins of 3.84% and 2.33%.
| Gross Margin | 15.21% |
| Operating Margin | 3.84% |
| Pretax Margin | 3.12% |
| Profit Margin | 2.33% |
| EBITDA Margin | 3.86% |
| EBIT Margin | 3.86% |
| FCF Margin | 2.91% |
Dividends & Yields
This stock pays an annual dividend of $2.66, which amounts to a dividend yield of 3.83%.
| Dividend Per Share | $2.66 |
| Dividend Yield | 3.83% |
| Dividend Growth (YoY) | 9.96% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 41.11% |
| Buyback Yield | 2.49% |
| Shareholder Yield | 6.33% |
| Earnings Yield | 9.56% |
| FCF Yield | 11.90% |
Analyst Forecast
The average price target for CVS Health is $89.67, which is 29.23% higher than the current price. The consensus rating is "Buy".
| Price Target | $89.67 |
| Price Target Difference | 29.23% |
| Analyst Consensus | Buy |
| Analyst Count | 22 |
| Revenue Growth Forecast (5Y) | 4.84% |
| EPS Growth Forecast (5Y) | 12.61% |
Stock Splits
The last stock split was on June 7, 2005. It was a forward split with a ratio of 2:1.
| Last Split Date | Jun 7, 2005 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
CVS Health has an Altman Z-Score of 2.21 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.21 |
| Piotroski F-Score | 6 |